EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cas9 Cis/Trans Cleavage Mechanisms: Cross-System CRISPR Insights and Diagnostic Applications

Xueying Li, Ying Chen, Linglong Huang, Jiyun Chen, Liang Liu

Health and Metabolism · 2025

DOI: 10.53941/hm.2025.100021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health and Metabolism, 2025. Verfasst von Xueying Li und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-Cas system is an adaptive immune system of prokaryotes against foreign invading viruses. Type II CRISPR-Cas9 system, as the earliest of the Class II systems to be discovered and applied to gene editing, has been recently found to possess trans-cleavage activity with other Class II systems not long ago. In this review, we summarize the molecular mechanism of cis- and trans-cleavage of target nucleic acids by the Class II type II CRISPR-Cas system, introduce the nucleic acid detection platforms developed based on its trans-cleavage activity, and compare them with those developed based on the type V, type VI, and type I CRISPR-Cas systems.

Zitieren

APA

Li, X., Chen, Y., Huang, L., Chen, J., & Liu, L. (2025). Cas9 Cis/Trans Cleavage Mechanisms: Cross-System CRISPR Insights and Diagnostic Applications. Health and Metabolism. https://doi.org/10.53941/hm.2025.100021

Vancouver

Li X, Chen Y, Huang L, Chen J, Liu L. Cas9 Cis/Trans Cleavage Mechanisms: Cross-System CRISPR Insights and Diagnostic Applications. Health and Metabolism. 2025. doi:10.53941/hm.2025.100021

BibTeX
@article{Li2025,
  author = {Li, Xueying and Chen, Ying and Huang, Linglong and Chen, Jiyun and Liu, Liang},
  title = {Cas9 Cis/Trans Cleavage Mechanisms: Cross-System CRISPR Insights and Diagnostic Applications},
  journal = {Health and Metabolism},
  year = {2025},
  doi = {10.53941/hm.2025.100021}
}
Kostenlos starten →